Intel: Three Signals Align as Earnings Day Nears

Why this matters: Three distinct data streams — options positioning, short covering, and borrow costs — are moving in the same direction for INTC with three days until the July 23 Q2 print. The convergence is notable precisely because the price action is not cooperating: the stock sits at $95.04, down 13% on the week and 19% on the month.

Converging Signals

Options market turns sharply bullish. The put/call ratio hit 0.92 on July 17. That is 2.4 standard deviations below the 20-day mean of 0.97 — the most call-heavy reading since January. The 52-week range runs from 0.61 to 1.16, so this reading sits closer to the bullish extreme than the bearish one. Call buyers are active on a name that has shed a fifth of its value in a month.

Short sellers have largely exited. SI % of free float stands at 2.66%, down from around 3.5% at end-June. The week-on-week decline runs at roughly 14%. Bears have been covering steadily since early July, and at current levels the short position is modest. There is no meaningful fuel here for a mechanical squeeze.

Borrow costs have collapsed. Cost to borrow sits at 0.31% — down 19% over the past week and 35% over the past month. The lending pool is extraordinarily loose. Availability is effectively uncapped, with over 4.5 billion shares available to lend. Bears who remain short are paying almost nothing for the privilege.

Corroborating Context

The analyst picture adds texture but not resolution. Five firms raised price targets in the past ten days — Keybanc to $155, BofA to $160, Goldman Sachs at $150, UBS to $121, TD Cowen to $115. The consensus mean now stands at $106.70. Intel at $95.04 trades at a 11% discount to that average — a notable reversal from the 42% premium that defined the June peak. Susquehanna raised its target to $115 from $80 on July 16, the most recent move.

Despite the target upgrades, only Keybanc and BofA carry outright bullish ratings. The rest maintain Neutral or Hold. Upgrades are tracking the stock's prior run-up, not leading a new one.

The EPS momentum factor scores are worth noting: 79th percentile on 30-day EPS momentum, 98th percentile on 90-day EPS momentum. Earnings estimate revisions have been strongly positive going into the print — a counterpoint to a stock that has given back most of its gains.

The ORTEX short score sits at 30.4, near recent lows, consistent with the short covering narrative.

Data Summary

• Price: $95.04 — down 13% on the week, 19% on the month
• SI % of free float: 2.66%, down ~14% week-on-week — multi-month low
• Cost to borrow: 0.31% — down 35% over past month; borrow market fully open
• Put/call ratio: 0.92 — 2.4 std devs below 20-day mean, most call-heavy in six months
• Consensus price target: $106.70 mean — stock now at an 11% discount
• Next earnings: July 23, after market close
• EPS momentum (90-day): 98th percentile

What to watch: Whether the call-heavy options positioning reflects informed conviction or simply speculative positioning on a beaten-down name is the question July 23 will answer directly.